158 related articles for article (PubMed ID: 7954394)
1. Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants.
Silletti S; Timar J; Honn KV; Raz A
Cancer Res; 1994 Nov; 54(22):5752-6. PubMed ID: 7954394
[TBL] [Abstract][Full Text] [Related]
2. Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.
Timar J; Silletti S; Bazaz R; Raz A; Honn KV
Int J Cancer; 1993 Dec; 55(6):1003-10. PubMed ID: 8253518
[TBL] [Abstract][Full Text] [Related]
3. Suppression of melanoma cell motility factor receptor expression by retinoic acid.
Lotan R; Amos B; Watanabe H; Raz A
Cancer Res; 1992 Sep; 52(18):4878-84. PubMed ID: 1325286
[TBL] [Abstract][Full Text] [Related]
4. Multiple use of a signal transduction pathway in tumor cell invasion.
Tímár J; Rásó E; Fazakas ZS; Silletti S; Raz A; Honn KV
Anticancer Res; 1996; 16(6A):3299-306. PubMed ID: 9042304
[TBL] [Abstract][Full Text] [Related]
5. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
Silletti S; Yao JP; Pienta KJ; Raz A
Int J Cancer; 1995 Sep; 63(1):100-5. PubMed ID: 7558435
[TBL] [Abstract][Full Text] [Related]
6. [The role of autocrine motility factor receptor in metastasis].
Watanabe H; Chigira M; Raz A
Gan To Kagaku Ryoho; 1993 Feb; 20(3):405-9. PubMed ID: 8382466
[TBL] [Abstract][Full Text] [Related]
7. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
Kojic LD; Wiseman SM; Ghaidi F; Joshi B; Nedev H; Saragovi HU; Nabi IR
PLoS One; 2008; 3(10):e3597. PubMed ID: 18974847
[TBL] [Abstract][Full Text] [Related]
8. Autocrine motility factor and its receptor: role in cell locomotion and metastasis.
Nabi IR; Watanabe H; Raz A
Cancer Metastasis Rev; 1992 Mar; 11(1):5-20. PubMed ID: 1324804
[TBL] [Abstract][Full Text] [Related]
9. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
[TBL] [Abstract][Full Text] [Related]
10. A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells.
Honn KV; Timár J; Rozhin J; Bazaz R; Sameni M; Ziegler G; Sloane BF
Exp Cell Res; 1994 Sep; 214(1):120-30. PubMed ID: 7521840
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential.
Liu B; Marnett LJ; Chaudhary A; Ji C; Blair IA; Johnson CR; Diglio CA; Honn KV
Lab Invest; 1994 Mar; 70(3):314-23. PubMed ID: 8145526
[TBL] [Abstract][Full Text] [Related]
12. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis.
Chen YQ; Duniec ZM; Liu B; Hagmann W; Gao X; Shimoji K; Marnett LJ; Johnson CR; Honn KV
Cancer Res; 1994 Mar; 54(6):1574-9. PubMed ID: 7511046
[TBL] [Abstract][Full Text] [Related]
13. Enhancement role of host 12/15-lipoxygenase in melanoma progression.
Kang KH; Ling TY; Liou HH; Huang YK; Hour MJ; Liou HC; Fu WM
Eur J Cancer; 2013 Aug; 49(12):2747-59. PubMed ID: 23664097
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell autocrine motility factor receptor.
Nabi IR; Watanabe H; Silletti S; Raz A
EXS; 1991; 59():163-77. PubMed ID: 1655517
[TBL] [Abstract][Full Text] [Related]
15. Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.
Timar J; Trikha M; Szekeres K; Bazaz R; Tovari J; Silletti S; Raz A; Honn KV
Cancer Res; 1996 Apr; 56(8):1902-8. PubMed ID: 8620512
[TBL] [Abstract][Full Text] [Related]
16. Autocrine motility factor is a growth factor.
Silletti S; Raz A
Biochem Biophys Res Commun; 1993 Jul; 194(1):446-57. PubMed ID: 8392842
[TBL] [Abstract][Full Text] [Related]
17. AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78.
Haga A; Komazaki S; Funasaka T; Hashimoto K; Yokoyama Y; Watanabe H; Raz A; Nagase H
Leuk Lymphoma; 2006 Oct; 47(10):2234-43. PubMed ID: 17071500
[TBL] [Abstract][Full Text] [Related]
18. Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jun; 284(5):1116-25. PubMed ID: 11414699
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of the AMF receptor by human melanoma in experimental and clinical systems.
Tímár J; Rásó E; Döme B; Ladányi A; Bánfalvi T; Gilde K; Raz A
Clin Exp Metastasis; 2002; 19(3):225-32. PubMed ID: 12067203
[TBL] [Abstract][Full Text] [Related]
20. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction.
Honn KV; Tang DG; Grossi I; Duniec ZM; Timar J; Renaud C; Leithauser M; Blair I; Johnson CR; Diglio CA
Cancer Res; 1994 Jan; 54(2):565-74. PubMed ID: 8275495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
